Belimumab With Rituximab for Primary Membranous Nephropathy
Conditions
Membranous Nephropathy · Nephrotic Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham School of Medicine: Division of Nephrology, Birmingham, Alabama, United States
Contact: Principal Investigator (Dana Rizk)University of Arkansas, Little Rock, Arkansas, United States
Contact: Principal Investigator (Srilakshmi Ravula)University of California San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Raymond Hsu)Stanford University School of Medicine: Division of Nephrology, Stanford, California, United States
Contact: Principal Investigator (Fahmeedah Kamal)The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension, Torrance, California, United States
Contact: Principal Investigator (Sharon G. Adler)University of Colorado, Aurora, Colorado, United States
Contact: Principal Investigator (Amber Podoll, MD)Mayo Clinic Jacksonville: Department of Nephrology and Hypertension, Jacksonville, Florida, United States
Contact: Principal Investigator (Nabeel Aslam)University of Miami Miller School of Medicine, Div of Nephrology, Miami, Florida, United States
Contact: Principal Investigator (Jair Munoz Mendoza)Johns Hopkins, Baltimore, Maryland, United States
Contact: Principal Investigator (Duvuru Geetha)National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Principal Investigator (Meryl A. Waldman)University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Andrea Oliverio)University of Minnesota Health Clinical Research Unit, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Patrick H. Nachman)Washington University in St. Louis, St Louis, Missouri, United States
Contact: Principal Investigator (Tinting Li)University of Nebraska, Omaha, Nebraska, United States
Contact: Principal Investigator (Prasanth Ravipati)Columbia University Medical Center: Division of Nephrology, New York, New York, United States
Contact: Principal Investigator (Andrew S. Bomback)University of North Carolina School of Medicine: Division of Nephrology and Hypertension, Kidney Center, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Vimal K. Derebail)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (John Sedor)Ohio State University Wexner Medical Center: Division of Nephrology, Columbus, Ohio, United States
Contact: Principal Investigator (Isabelle Ayoub)University of Pennsylvania: Department of Medicine: Renal-Electrolyte and Hypertension Division, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Krishna Kallem, MD, MPH) · Krishna.Kallem@pennmedicine.upenn.edu · 484-358-0315Contact: Principal Investigator (Gaia Coppock)Providence Medical Research Center, Providence Health Care: Nephrology, Spokane, Washington, United States
Contact: Principal Investigator (Katherine R. Tuttle)
Study leads
Patrick Nachman
Study Chair
University of Minnesota, Department of Medicine, Division of Renal Diseases and Hypertension
Iñaki Sanz
Study Chair
Emory University, Department of Medicine, Division of Rheumatology